PO.TB10.07 · 肿瘤生物学
PaintScape™在完整新鲜冷冻胶质母细胞瘤组织的天然肿瘤微环境中实现单细胞空间3D基因组结构的多组学原位直接可视化
PaintScape TM enables multiomic in-situ direct visualization of spatial 3D genome architecture of single cells in intact fresh frozen Glioblastoma tissue in native tumor microenvironments
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
基因组结构的三维组织在调控基因表达和细胞功能中发挥关键作用,其在包括胶质母细胞瘤(GBM)在内的多种癌症中常发生重构。GBM以极端的分子和表型多样性为特征,是最具侵袭性和致死性的脑癌形式,常在不同肿瘤微环境中跨基因组、表观基因组、转录组和蛋白质组信号网络表现出克隆和亚克隆变异。诸如拷贝数变异(CNVs)、结构变异(SVs)和拓扑变化等结构畸变会重新连接3D基因组,导致致癌基因的异常激活、肿瘤抑制基因的抑制以及基因表达的失调。当前诸如WGS或Hi-C等方法提供了对失调的bulk水平理解,但缺乏单细胞空间分辨率,且无法提供关于完整组织中分子亚克隆与微环境之间空间分布和关联的见解。由于肿瘤异质性驱动治疗耐药并阻碍GBM的成功治疗,在异质性空间背景下理解分子机制需要最先进的原位单细胞和空间技术,以便为早期检测和疾病进展提供更深入的见解。
在本研究中,我们提出了一种基于PaintScape™平台的新型多组学jebFISH™方案,可用于分析并直接可视化不同组织微环境(如坏死周围、血管周围、浸润性)中新鲜冷冻GBM细胞在单细胞、亚群体和群体水平的3D染色质结构。使用ChromoPaint™ PanChromo MPX Panel(可可视化所有染色体上超过400个位点),我们展示了完整GBM组织中单个染色体3D折叠的破坏,如染色体领域的重组、p-q臂相互作用的差异、单细胞和亚群体水平的染色体内和染色体间邻近性。通过将jebFISH与缺氧和微血管的多重免疫荧光蛋白质组学检测相结合,我们展示了同一GBM组织切片内不同组织微环境(例如缺氧区与常氧区)在癌细胞亚群中如何具有不同的3D基因组畸变和结构组织。我们在组织内原位表征了不同GBM癌细胞和免疫细胞状态在亚染色体水平的染色体不稳定性、CNVs和SVs。
PaintScape系统将通过更深入地揭示完整组织微环境中具有独特空间背景的单个癌细胞和亚群的3D基因组异质性,增进对胶质母细胞瘤疾病进展的理解,未来有可能指导更好的癌症治疗设计。
查看英文原文 English abstract
The 3D organization of genome structure, which plays a critical role in regulating gene expression and cellular function, is often restructured in many different cancers including Glioblastoma (GBM). Characterized by extreme molecular and phenotypic diversity, GBM is the most aggressive and lethal form of brain cancer and often show clonal and sub-clonal variations across genomic, epigenomic, transcriptomic, and proteomic signaling networks within distinct tumor microenvironments. Structural aberrations such as copy number variations (CNVs), structural variations (SVs), and topological changes rewire the 3D genome allowing aberrant activation of oncogenes, repression of tumor suppressors and dysregulation in gene expression. Current methods such as WGS or Hi-C provide bulk-level understanding of dysregulation but lack single-cell spatial resolution and do not provide insight into spatial distribution and association between molecular subclones and microenvironment in intact tissue. Since tumor heterogeneity drives therapy resistance and hinders successful GBM treatment, understanding the molecular mechanism in a heterogenous spatial context demands state-of-the-art in-situ single cell and spatial technologies that can provide deeper insight into early detection and disease progression.
In this study, we present a novel multiomic jebFISH TM protocol on the PaintScape TM platform that can be used to analyze and directly visualize 3D chromatin architecture of fresh frozen GBM cells in different tissue microenvironments such as perinecrotic, perivascular, infiltrative, at single-cell, sub-population and population level. Using the ChromoPaint™ PanChromo MPX Panel, which visualizes over 400 loci across all chromosomes, we show disruption in 3D folding of individual chromosomes such as re-organization of chromosome territory, differential p-q arm interaction, intra and inter-chromosomal proximity at single cell and sub-population level in intact GBM tissue. By combining jebFISH with multiplexed immunofluorescence proteomic detection of hypoxia and microvasculature, we show how different tissue microenvironment e.g. hypoxic vs normoxic regions within the same GBM tissue section have different 3D genome aberrations and structural organization in the cancer cell sub-populations. We characterize chromosomal instability, CNVs and SVs of different GBM cancer cell and immune cell states at sub-chromosomal level in-situ within the tissue.
The PaintScape system will enhance understanding of glioblastoma disease progression by providing deeper insight into the 3D genomic heterogeneity of single cancer cells and sub-populations with unique spatial context within intact tissue microenvironments, potentially guiding better cancer treatment design in the future.
利益披露 Disclosure
M. Snuderl,
HaloDx Scientific advisor, shareholder.
Heidelberg Epignostix Scientific advisor, shareholder.
Arima Genomics Scientific advisor.
InnoSIGN Scientific advisor.
Servier Pharmaceutical Consultant.
Y. Wang, None..
N. Dhasmana, None.
P. Flatley,
Bruker Spatial Genomics Employment.
S. Elliott,
Bruker Spatial Genomics Employment, Stock Option.
D. Werner,
Bruker Spatial Genomics Employment, Stock Option.
J. Dunne,
Bruker Spatial Genomics Employment, Stock Option.
H. Nguyen,
Bruker Spatial Genomics Employment, Stock Option.
S. Chattoraj,
Bruker Spatial Genomics Employment, Stock Option.